Guidelines on Developing Consumer Information on Proper Use of Traditional, Complementary and Alternative Medicine
(2004; 109 pages) View the PDF document
Table of Contents
View the documentAcknowledgements
View the documentForeword
View the documentPreface
View the documentGlossary
Open this folder and view contents1. General Considerations
Open this folder and view contents2. Development of Consumer Information
Open this folder and view contents3. General Principles and Activities for Ensuring Reliable TM/CAM Information
Close this folder4. Topics to Consider when Developing Consumer Information Promoting Proper Use of TM/CAM
View the document4.1 General information
View the document4.2 Where to find reliable information
View the document4.3 How to identify reliable information
Open this folder and view contents4.4 TM/CAM medication therapies
Open this folder and view contents4.5 Procedure-based TM/CAM therapies
View the document4.6 Practitioners
View the document4.7 Pricing and health insurance coverage
View the document5. Use of this Publication
View the documentReferences
Open this folder and view contentsAnnexes
View the documentBack Cover

4. Topics to Consider when Developing Consumer Information Promoting Proper Use of TM/CAM

Information/education about the advantages and the disadvantages of certain TM/CAM therapies is key to enabling consumers to make an informed choice. This information may include issues such as methods of diagnosis and treatment, benefits, risks, philosophy of the TM/CAM therapy concerned, health promotion and maintenance strategies. However, the content will vary depending on the country- specific features of TM/CAM. For example, the structure of the health system and rate of TM/CAM utilization will influence the degree of familiarity with this kind of medicine and the level of knowledge among consumers.

National or local authorities need to decide which specific TM/CAM therapies should be included in the information initiatives. The popularity of TM/CAM therapies as well as safety, quality and efficacy concerns will determine which ones should be included. The national or international evidence base for a certain therapy may also influence its inclusion. The following sections outline different topics to consider when developing consumer information. These are summarized in table 1.

to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017